Literature DB >> 30116604

Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies.

Zhengtu Li1, Li Li2, Shuai Zhao3, Jing Li1, Hongxia Zhou1, Yunhui Zhang4, Zifeng Yang1,5, Bing Yuan1,4.   

Abstract

The direct replication of influenza virus is not the only cause of harm to human health; influenza infection leading to a hyper-inflammatory immune response can also result in serious conditions. So, the treatment strategy for influenza needs to keep balance between antivirus and anti-inflammation. Herein, we review the treatment strategies of anti-influenza drugs and traditional Chinese medicines.

Entities:  

Keywords:  Influenza; anti-inflammation; antivirus; chemical drug; traditional Chinese medicine

Year:  2018        PMID： 30116604      PMCID： PMC6072919          DOI： 10.21037/jtd.2018.03.169

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  103 in total

1.  Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells.

Authors:  Chris K P Mok; Sara S R Kang; Renee W Y Chan; Patrick Y K Yue; Nai K Mak; Leo L M Poon; Ricky N S Wong; J S Malik Peiris; Michael C W Chan
Journal:  Antiviral Res       Date:  2014-04-06       Impact factor: 5.970

2.  The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly.

Authors:  Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Takeshi Noda; Maki Kiso; Junko Maeda; Shinji Watanabe; Yukiko Muramoto; Ken Fujii; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

3.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

4.  IL-17 response mediates acute lung injury induced by the 2009 pandemic influenza A (H1N1) virus.

Authors:  Chenggang Li; Penghui Yang; Yang Sun; Taisheng Li; Chen Wang; Zhong Wang; Zhen Zou; Yiwu Yan; Wei Wang; Chen Wang; Zhongwei Chen; Li Xing; Chong Tang; Xiangwu Ju; Feng Guo; Jiejie Deng; Yan Zhao; Peng Yang; Jun Tang; Huanling Wang; Zhongpeng Zhao; Zhinan Yin; Bin Cao; Xiliang Wang; Chengyu Jiang
Journal:  Cell Res       Date:  2011-10-25       Impact factor: 25.617

Review 5.  Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.

Authors:  Hiroshi Kido; Yuushi Okumura; Hiroshi Yamada; Trong Quang Le; Mihiro Yano
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

6.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Authors:  Bin Cao; Xing-Wang Li; Yu Mao; Jian Wang; Hong-Zhou Lu; Yu-Sheng Chen; Zong-An Liang; Lirong Liang; Su-Juan Zhang; Bin Zhang; Li Gu; Lian-He Lu; Da-Yan Wang; Chen Wang
Journal:  N Engl J Med       Date:  2009-12-09       Impact factor: 91.245

Review 7.  Innate immune responses to influenza A H5N1: friend or foe?

Authors:  Joseph Sriyal Malik Peiris; Chung Yan Cheung; Connie Yin Hung Leung; John Malcolm Nicholls
Journal:  Trends Immunol       Date:  2009-10-26       Impact factor: 16.687

8.  Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.

Authors:  Natalia Hagau; Adriana Slavcovici; Daniel N Gonganau; Simona Oltean; Dan S Dirzu; Erika S Brezoszki; Mihaela Maxim; Constantin Ciuce; Monica Mlesnite; Rodica L Gavrus; Carmen Laslo; Radu Hagau; Magda Petrescu; Daniela M Studnicska
Journal:  Crit Care       Date:  2010-11-09       Impact factor: 9.097

9.  Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study.

Authors:  Yan Zhang; Hainv Gao; Weifeng Liang; Lingling Tang; Yida Yang; Xiaoxin Wu; Liang Yu; Ping Chen; Shufa Zheng; Huilin Ou; Lanjuan Li
Journal:  BMC Infect Dis       Date:  2016-02-10       Impact factor: 3.090

10.  Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations.

Authors:  Guoying Dong; Chao Peng; Jing Luo; Chengmin Wang; Le Han; Bin Wu; Guangju Ji; Hongxuan He
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240
View more
  3 in total

1.  A novel aqueous extract from rice fermented with Aspergillus oryzae and Saccharomyces cerevisiae possesses an anti-influenza A virus activity.

Authors:  Masaki Shoji; Minami Sugimoto; Kosuke Matsuno; Yoko Fujita; Tomohiro Mii; Satomi Ayaki; Misa Takeuchi; Saki Yamaji; Narue Tanaka; Etsuhisa Takahashi; Takeshi Noda; Hiroshi Kido; Takaaki Tokuyama; Takahito Tokuyama; Takashi Tokuyama; Takashi Kuzuhara
Journal:  PLoS One       Date:  2021-01-15       Impact factor: 3.240

2.  Exploring the total flavones of Abelmoschus manihot against IAV-induced lung inflammation by network pharmacology.

Authors:  Yanan Gao; Zihao Liang; Nianyin Lv; Jinjun Shan; Huihui Zhou; Junfeng Zhang; Liyun Shi
Journal:  BMC Complement Med Ther       Date:  2022-02-05

Review 3.  Comparison of COVID-19 and influenza characteristics.

Authors:  Yu Bai; Xiaonan Tao
Journal:  J Zhejiang Univ Sci B       Date:  2021-02-15       Impact factor: 3.066
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.